ES2073922T3 - Procedimiento para mejorar la eficacia terapeutica de agentes antifungicos liposolubles de la familia de los imidazoles y composicion para la realizacion de este procedimiento. - Google Patents

Procedimiento para mejorar la eficacia terapeutica de agentes antifungicos liposolubles de la familia de los imidazoles y composicion para la realizacion de este procedimiento.

Info

Publication number
ES2073922T3
ES2073922T3 ES92910451T ES92910451T ES2073922T3 ES 2073922 T3 ES2073922 T3 ES 2073922T3 ES 92910451 T ES92910451 T ES 92910451T ES 92910451 T ES92910451 T ES 92910451T ES 2073922 T3 ES2073922 T3 ES 2073922T3
Authority
ES
Spain
Prior art keywords
procedure
family
liposoluble
imidazoles
performance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910451T
Other languages
English (en)
Inventor
Jean-Pierre Laugier
Evelyne Segot
Jean-Thierry Simonnet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of ES2073922T3 publication Critical patent/ES2073922T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EN EL PROCESO SEGUN LA INVENCION, AL MENOS UN AGENTE ANTIFUNGICO DE LA FAMILIA DE LOS IMIDAZOLES ES INTRODUCIDO EN UNA FASE LIPIDICA ANFIFILICA NO IONICA SUSCEPTIBLE DE FORMAR, POR DISPERSION EN UNA FASE ACUOSA, VESICULAS CONSTITUIDAS DE CAPAS LAMINARES, ENCAPSULANDO DICHAS VESICULAS UNA FASE ACUOSA Y ESTANDO FORMADAS DE MANERA CONOCIDA; SE ELIGE, COMO LIPIDO(S) ANFIFILICO(S) NO IONICO(S), UNO (O VARIOS) LIPIDO(S) DE DOS CADENAS GRASAS Y SE AJUSTA EL PH DE LA FASE VESICULAR ANTES DE LA DISPERSION MEDIANTE AL MENOS UNA BASE A UN VALOR COMPRENDIDO ENTRE 6 Y 8.
ES92910451T 1991-05-03 1992-04-29 Procedimiento para mejorar la eficacia terapeutica de agentes antifungicos liposolubles de la familia de los imidazoles y composicion para la realizacion de este procedimiento. Expired - Lifetime ES2073922T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9105458A FR2675998B1 (fr) 1991-05-03 1991-05-03 Procede pour ameliorer l'efficacite therapeutique d'agents antifongiques liposolubles de la famille des imidazoles et composition pour la mise en óoeuvre de ce procede.

Publications (1)

Publication Number Publication Date
ES2073922T3 true ES2073922T3 (es) 1995-08-16

Family

ID=9412496

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910451T Expired - Lifetime ES2073922T3 (es) 1991-05-03 1992-04-29 Procedimiento para mejorar la eficacia terapeutica de agentes antifungicos liposolubles de la familia de los imidazoles y composicion para la realizacion de este procedimiento.

Country Status (5)

Country Link
EP (1) EP0538442B1 (es)
DE (1) DE69203071T2 (es)
ES (1) ES2073922T3 (es)
FR (1) FR2675998B1 (es)
WO (1) WO1992019225A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT408067B (de) * 1995-03-17 2001-08-27 Gebro Pharma Gmbh Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
EP1264632A1 (de) * 2001-06-08 2002-12-11 Cognis Iberia, S.L. Verwendung von Alkyl(ether)phosphaten(III)
FR2842734A1 (fr) * 2002-07-24 2004-01-30 Ethypharm Sa Procede pour diminuer la variabilite de la biodisponibilite d'un medicament a administration orale et compositions pharmaceutiques a administration orale
CN110075310A (zh) 2011-12-20 2019-08-02 维奥姆治疗有限公司 用于治疗真菌感染的局部油组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597345B1 (fr) * 1986-04-22 1990-08-03 Oreal Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
EP0382777B1 (en) * 1987-10-19 1994-10-12 The Liposome Company, Inc. Aqueous preparation of liposome composition
JPH02204413A (ja) * 1989-02-02 1990-08-14 Nonogawa Shoji:Kk 抗真菌外用製剤

Also Published As

Publication number Publication date
FR2675998B1 (fr) 1995-03-10
EP0538442B1 (fr) 1995-06-21
WO1992019225A1 (fr) 1992-11-12
EP0538442A1 (fr) 1993-04-28
DE69203071D1 (de) 1995-07-27
FR2675998A1 (fr) 1992-11-06
DE69203071T2 (de) 1996-03-07

Similar Documents

Publication Publication Date Title
CO4440476A1 (es) Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos .
ES2037681T3 (es) Procedimiento para preparar nuevos estirilpirazoles, isoxazoles y analogos de los mismos que tienen actividad como inhibidores de 5-lipoxigenasa.
ES2118160T3 (es) Compuestos de azol, su produccion y su uso.
ES2087665T3 (es) N-acetonilbenzamidas y su uso como fungicidas.
ES2192201T3 (es) Compuestos de piranona utiles para el tratamiento de infecciones retrovirales.
ES8404348A1 (es) Un procedimiento para la preparacion de agentes antifungicos triazolicos.
ES2052881T3 (es) Agentes reductores de la presion sanguinea.
IT8123700A0 (it) L'applicazione in terapeutica dei derivati del 4,5,6,7-tetraidroisossozolo(5,4-c)piridin-3-olo come miotonolitici.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
DE2962527D1 (en) Hydroxyethyl azoles, process for their preparation and their use in medicaments
ATE6988T1 (de) Antimykotische mittel mit hoher wirkstofffreisetzung in form von stiften.
ES2107035T3 (es) Derivados de 3-azabiciclo(3.2.0)heptano n-substituidos como neurolepticos etc..
PH16119A (en) New hydroxypropyl-triazole compound,their composition and medicinal use
ES2073922T3 (es) Procedimiento para mejorar la eficacia terapeutica de agentes antifungicos liposolubles de la familia de los imidazoles y composicion para la realizacion de este procedimiento.
ES2072536T3 (es) Derivados de tiazolidina que presentan actividad anti-hipertensiva y su uso en terapeutica.
ES2178425T3 (es) Agente protector contra el sol.
EP0588796A4 (en) New compounds and compositions useful as antifungal and antimycobacterial agents
ATE232686T1 (de) Sporizide zusammensetzung
ES2058264T3 (es) Sulfonildecahidro-8h-isoquino(2,1-g)(1,6)naftiridinas, isomeros opticos de las mismas y compuestos afines.
DK175683D0 (da) Fungicidt middel
FI822331L (fi) Blandningar foer lokal anvaendning pao huden
ATE33759T1 (de) Antimykotische mittel in gelform zur behandlung von pilzinfektionen der mundhoehle.
ES2093752T3 (es) Complejos de hierro que contienen conalbumina y sus derivados.
PE20001145A1 (es) Mezclas fungicidas
TR200000154T2 (tr) 2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 538442

Country of ref document: ES